Citadel Advisors
DERM

Citadel Advisors’s Dermira, Inc. DERM Stock Holding History

Citadel Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-33,800
Closed -$512K – 10556
2019
Q4 		$512K Buy
+33,800
New +$292K ﹤0.01% 6769
2019
Q3 		– Sell
-32,100
Closed -$307K – 10091
2019
Q2 		$307K Sell
32,100
-190,500
-86% -$2.05M ﹤0.01% 7553
2019
Q1 		$3.02M Buy
222,600
+198,000
+805% +$1.65M ﹤0.01% 3753
2018
Q4 		$177K Sell
24,600
-23,800
-49% -$260K ﹤0.01% 7955
2018
Q3 		$528K Buy
48,400
+15,600
+48% +$157K ﹤0.01% 6604
2018
Q2 		$302K Buy
32,800
+6,800
+26% +$63.4K ﹤0.01% 7201
2018
Q1 		$208K Buy
26,000
+6,000
+30% +$131K ﹤0.01% 7303
2017
Q4 		$556K Buy
20,000
+2,000
+11% +$53K ﹤0.01% 5495
2017
Q3 		$486K Sell
18,000
-1,000
-5% -$26.2K ﹤0.01% 5377
2017
Q2 		$554K Buy
19,000
+5,600
+42% +$170K ﹤0.01% 4972
2017
Q1 		$457K Buy
13,400
+1,100
+9% +$35.5K ﹤0.01% 5181
2016
Q4 		$373K Buy
+12,300
New +$396K ﹤0.01% 5358

Citadel Advisors's DERM Position: Q1 2020 in Review

Citadel Advisors sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 255,772 shares — an estimated $3.88M sold.

Citadel Advisors first reported a position in DERM in Q3 2015 and held it in 13 quarters. The position peaked at $13.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Citadel Advisors reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Citadel Advisors sold 255,772 Dermira, Inc. shares in Q1 2020, an estimated $3.88M.
  • Citadel Advisors first reported a position in Dermira, Inc. in Q3 2015 and held it in 13 quarters.
  • Citadel Advisors's Dermira, Inc. position peaked at $13.3M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.